Abacavir, lamivudine, and zidovudine and Incruse Ellipta
Determining the interaction of Abacavir, lamivudine, and zidovudine and Incruse Ellipta and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: abacavir / lamivudine / zidovudine
Brand name: Trizivir
Synonyms: Abacavir, Lamivudine, and Zidovudine
Generic Name: umeclidinium
Brand name: Incruse Ellipta
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Abacavir, lamivudine, and zidovudine-Indacaterol
- Abacavir, lamivudine, and zidovudine-Indacaterol and Glycopyrrolate
- Abacavir, lamivudine, and zidovudine-Indacaterol and glycopyrrolate Inhalation
- Abacavir, lamivudine, and zidovudine-Indacaterol inhalation
- Abacavir, lamivudine, and zidovudine-Indacaterol Maleate
- Abacavir, lamivudine, and zidovudine-Indapamide
- Incruse Ellipta-Abaloparatide
- Incruse Ellipta-Abaloparatide Subcutaneous
- Incruse Ellipta-Abatacept
- Incruse Ellipta-Abatacept Auto-Injectors
- Incruse Ellipta-Abatacept Infusion
- Incruse Ellipta-Abatacept Intravenous